Seeking Alpha

CVS Caremark earnings call: Dissecting the tobacco exit

  • Execs with CVS Caremark (CVS -0.3%) cleared up some of the haze over what the impact of the exit of from the tobacco business will be during the firm's earnings call.
  • CVS lost 110 bps from its front store comp sales mark during Q2 and the development contributed to an overall loss in market share for drugstore traffic.
  • A 400-500 bp loss in front store sales growth is expected in Q3.
  • Overall, CVS says it will lose $2B in annual sales from the tobacco decision.
  • There isn't any specific guidance from the company on how much of the $2B will be made up and when by signing new healthcare services and provider deals.
  • Earnings call transcript
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs